[ Price : $8.95]
FDA grants Seattle Genetics a breakthrough therapy designation for Adcetris (brentuximab vedotin) for treating patients with CD30-...[ Price : $8.95]
Retrophin reaches an agreement with FDA under a Special Protocol Assessment for a Phase 3 clinical trial evaluating RE-024, an in...[ Price : $8.95]
President-elect Donald Trump reportedly selected former HHS official Andrew Bremberg to lead the transition team for HHS.[ Price : $8.95]
Pennsylvania-based medical device manufacturer Biocompatibles pleads guilty to misbranding its embolic device LC Bead and will pay...[ Price : $8.95]
FDA approves a Gilead Sciences NDA for Vemlidy (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic h...[ Price : $8.95]
Former FDAer Wayne Pines outlines three impacts of the election results on FDA in the future.[ Price : $8.95]
The HHS Inspector General releases a 2017 work plan with five items relating to FDA oversight of drugs and medical devices.[ Price : $8.95]
FDA denies on procedural grounds a Virtus Pharmaceutical petition asking it to investigate whether two producers of potassium chlo...